As it takes Lartru­vo off the shelves, Lil­ly is set­ting up pro­gram to pro­vide drug ac­cess to cur­rent pa­tients

When Lil­ly’s ap­proved soft tis­sue sar­co­ma drug Lartru­vo un­ex­pect­ed­ly failed to help pa­tients live longer in a late-stage study in Jan­u­ary, US and EU …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.